Status:
COMPLETED
Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease
Lead Sponsor:
Zealand University Hospital
Conditions:
Chronic Kidney Disease
Hypomagnesemia
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Randomized placebo-controlled interventional trial to investigate the effect of oral magnesium supplementation on intracellular magnesium in subjects with chronic kidney disease. We hypothesize that o...
Detailed Description
Chronic kidney disease (CKD) is associated with increase cardiovascular morbidity and mortality independent of traditional cardiovascular risk factors due to increased vascular calcification. Epidemio...
Eligibility Criteria
Inclusion
- Estimated Glomerular filtration rate (eGFR) \< 60 mL/min.
- Serum magnesium \< 0.82 mmol/L.
- Written informed consent.
Exclusion
- Hemodialysis.
- Peritoneal dialysis.
- Kidney transplant recipient.
- Parathyroid hormone \> 600 pg/L.
- Pregnancy.
- Comorbidity that makes study participation and completion impossible.
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT02216877
Start Date
August 1 2014
End Date
April 1 2015
Last Update
April 28 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medicine, Division of Nephrology, Roskilde County Hospital
Roskilde, Denmark